GreenLight Biosciences Announces Expiration Of Tender Offer Period For Outstanding Shares
Portfolio Pulse from Happy Mohamed
GreenLight Biosciences Holdings (NASDAQ:GRNA) is finalizing its merger with SW MergerCo, Inc. and SW ParentCo, Inc. Post-merger, GreenLight's common stock will cease trading on the NASDAQ after market close on July 20, 2023. The tender offer for GreenLight's outstanding shares expired on July 19, 2023, with approximately 60.4% of the shares validly tendered. Remaining shares not purchased in the offer will be converted into the right to receive $0.30 in cash.
July 20, 2023 | 12:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GreenLight Biosciences is finalizing its merger, and its common stock will cease trading on the NASDAQ. The tender offer for its outstanding shares has expired, with 60.4% of the shares validly tendered.
The news directly pertains to GreenLight Biosciences and its merger. The company's stock will cease trading on the NASDAQ, which will likely negatively impact the stock price in the short term. The tender offer for the company's outstanding shares has expired, which could also influence the stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100